Table 3.
Reported Use of Cannabidiol Products to Manage Symptoms of Health Concerns, Among Past 12-Month Cannabidiol Consumers
Health concerna |
Canada (n=2433) |
United States (n=7895) |
---|---|---|
Mental health | % (n) | % (n) |
Anxiety (including phobia, obsessive compulsive disorder, or panic disorder) | 44.1 (1073) | 51.5 (4064) |
Depression (including dysthymia) | 30.3 (736) | 34.0 (2688) |
PTSD or traumatic event (e.g., abuse or loss) | 14.2 (346) | 14.7 (1159) |
Bipolar disorder, mania, or borderline personality disorder | 6.4 (155) | 9.4 (9.4) |
ADD/ADHD | 6.3 (154) | 7.0 (552) |
Alcohol or other drug use | 4.4 (106) | 5.9 (464) |
Eating disorder | 4.7 (114) | 4.3 (336) |
Psychosis (e.g., paranoia, disorganized thinking, hearing voices that others can't hear) or dissociative identity disorder | 4.7 (114) | 4.6 (362) |
Schizophrenia | 2.6 (63) | 3.1 (247) |
Other significant emotional or mental health problem | 7.3 (179) | 6.7 (531) |
I have never used CBD products for any of the above | 34.0 (828) | 27.5 (2168) |
Unstated | 4.7 (115) | 5.2 (413) |
Physical health | ||
Pain (including muscle pain, arthritis, neuropathy, or PMS) | 46.9 (1141) | 52.1 (4110) |
Headaches/migraines | 29.9 (726) | 33.5 (2643) |
Problems sleeping | 27.4 (667) | 27.1 (2140) |
General well being | 13.9 (338) | 14.6 (1155) |
Muscle spasms | 10.9 (265) | 13.4 (1057) |
Nausea/vomiting or chemotherapy symptoms | 11.0 (268) | 12.8 (1011) |
Lack of appetite | 10.8 (263) | 11.7 (922) |
Digestion/gastrointestinal issues (Crohn's disease, colitis, IBS, IBD, etc.) | 6.7 (163) | 6.2 (491) |
Fibromyalgia | 5.1 (125) | 5.5 (437) |
Seizures/epilepsy | 5.1 (124) | 4.7 (371) |
To shrink tumors or treat cancer | 3.1 (75) | 2.9 (232) |
Other condition(s) | 3.4 (83) | 2.7 (212) |
I have never used CBD products for any of the above | 14.1 (342) | 11.8 (934) |
Unstated | 4.8 (117) | 4.6 (364) |
Respondents were asked: “Have you ever used CBD-only products with no THC to improve or manage symptoms for any of the following?” Mental and physical health conditions were shown on separate screens. Respondents could select all responses that applied; therefore, values do not sum to 100%.
ADD, attention deficit disorder; ADHD, attention deficit hyperactivity disorder; CBD, cannabidiol; IBD, inflammatory bowel disease; IBS, irritable bowel syndrome; PMS, pre-menstrual syndrome; PTSD, post-traumatic stress disorder; THC, tetrahydrocannabinol.